SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing the crucial role Pressure BioSciences ...
- Marketwired•2 days agoPressure BioSciences' PCT Platform Featured at Official Launch of Major Cancer Research Center Recently Chosen as a Collaborator in the US "Cancer Moonshot" Initiative
Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling pressure cycling technology -based sample preparation solutions to the large and growing worldwide life sciences industry, ...
- Accesswire•11 days agoPressure BioSciences, Inc. to Present at the Fall SeeThruEquity Microcap Investment Conference in New York City
SOUTH EASTON, MA / ACCESSWIRE / October 17, 2016 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, President and CEO, ...
Pressure BioSciences, Inc. (PBIO)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.30 - 0.32|
|52wk Range||0.20 - 0.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.77|
|Avg Vol (3m)||51,726|
|Dividend & Yield||N/A (N/A)|